CNBC’s Jim Cramer on Wednesday reviewed ten stocks worth more than $1 billion that have run up big this year, including Cava, ...

Bitcoin rallied above $89,000 Monday, marking another record after the U.S. elections. Analysts say it's time to buy cryptos, ...

CNBC’s Jim Cramer suggested that if Trump’s new tax plans are similar to those he implemented in 2016, wealthy people will ...

Amgen Inc.‘s AMGN stock dropped over 7% on Tuesday following revelations about bone density loss in early trials of its ...

CNBC’s Jim Cramer on Wednesday told investors the Trump administration is more likely to allow mergers and acquisitions to go through.

We recently published a list of Jim Cramer is Talking About These 10 Stocks. In this article, we are going to take a look at where Arm Holdings plc (NASDAQ:ARM) stands against other stocks Jim Cramer ...

We recently published a list of Jim Cramer is Talking About These 10 Stocks. In this article, we are going to take a look at where NVIDIA Corporation (NASDAQ:NVDA) stands against other stocks Jim ...

We recently compiled a list of the Jim Cramer’s Latest Lightning Round: 11 Stocks to Watch. In this article, we are going to take a look at where QUALCOMM Incorporated (NASDAQ:QCOM) stands against the ...

Mohit Bansal, an analyst from Wells Fargo, maintained the Hold rating on Pfizer (PFE – Research Report). The associated price target remains the same with $30.00. Mohit Bansal has given his Hold ...

Pfizer Chairman and CEO Albert Bourla joins 'Mad Money' host Jim Cramer to talk quarterly results, what's in the pipeline, ...

CNBC's Jim Cramer on Tuesday lamented rising bond yields' effect on the market, saying this action could narrow the rally to tech and diminish broader sector gains. "If the bond market doesn't ...

In a Tuesday interview with CNBC's Jim Cramer, Pfizer CEO Albert Bourla struck a positive tone about activist investor ...